Cargando…
A robust synthesis of 7,8-didemethyl-8-hydroxy-5-deazariboflavin
The biosynthetic precursor of redox cofactor F420, 7,8-didemethyl-8-hydroxy-5-deazariboflavin, was prepared in four steps from 6-chlorouracil, 2-chloro-4-hydroxybenzaldehyde and bis-isopropylidene protected D-ribose. The latter aldehyde was transformed to the corresponding protected ribitylamine via...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901869/ https://www.ncbi.nlm.nih.gov/pubmed/27340481 http://dx.doi.org/10.3762/bjoc.12.89 |
_version_ | 1782436889954877440 |
---|---|
author | Bender, Matthias Mouritsen, Henrik Christoffers, Jens |
author_facet | Bender, Matthias Mouritsen, Henrik Christoffers, Jens |
author_sort | Bender, Matthias |
collection | PubMed |
description | The biosynthetic precursor of redox cofactor F420, 7,8-didemethyl-8-hydroxy-5-deazariboflavin, was prepared in four steps from 6-chlorouracil, 2-chloro-4-hydroxybenzaldehyde and bis-isopropylidene protected D-ribose. The latter aldehyde was transformed to the corresponding protected ribitylamine via the oxime, which was submitted to reduction with LiAlH(4). Key advantage compared to previous syntheses is the utilization of a polyol-protective group which allowed the chromatographic purification of a key-intermediate product providing the target compound with high purity. |
format | Online Article Text |
id | pubmed-4901869 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Beilstein-Institut |
record_format | MEDLINE/PubMed |
spelling | pubmed-49018692016-06-23 A robust synthesis of 7,8-didemethyl-8-hydroxy-5-deazariboflavin Bender, Matthias Mouritsen, Henrik Christoffers, Jens Beilstein J Org Chem Full Research Paper The biosynthetic precursor of redox cofactor F420, 7,8-didemethyl-8-hydroxy-5-deazariboflavin, was prepared in four steps from 6-chlorouracil, 2-chloro-4-hydroxybenzaldehyde and bis-isopropylidene protected D-ribose. The latter aldehyde was transformed to the corresponding protected ribitylamine via the oxime, which was submitted to reduction with LiAlH(4). Key advantage compared to previous syntheses is the utilization of a polyol-protective group which allowed the chromatographic purification of a key-intermediate product providing the target compound with high purity. Beilstein-Institut 2016-05-06 /pmc/articles/PMC4901869/ /pubmed/27340481 http://dx.doi.org/10.3762/bjoc.12.89 Text en Copyright © 2016, Bender et al. https://creativecommons.org/licenses/by/2.0https://www.beilstein-journals.org/bjoc/termsThis is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (https://www.beilstein-journals.org/bjoc/terms) |
spellingShingle | Full Research Paper Bender, Matthias Mouritsen, Henrik Christoffers, Jens A robust synthesis of 7,8-didemethyl-8-hydroxy-5-deazariboflavin |
title | A robust synthesis of 7,8-didemethyl-8-hydroxy-5-deazariboflavin |
title_full | A robust synthesis of 7,8-didemethyl-8-hydroxy-5-deazariboflavin |
title_fullStr | A robust synthesis of 7,8-didemethyl-8-hydroxy-5-deazariboflavin |
title_full_unstemmed | A robust synthesis of 7,8-didemethyl-8-hydroxy-5-deazariboflavin |
title_short | A robust synthesis of 7,8-didemethyl-8-hydroxy-5-deazariboflavin |
title_sort | robust synthesis of 7,8-didemethyl-8-hydroxy-5-deazariboflavin |
topic | Full Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901869/ https://www.ncbi.nlm.nih.gov/pubmed/27340481 http://dx.doi.org/10.3762/bjoc.12.89 |
work_keys_str_mv | AT bendermatthias arobustsynthesisof78didemethyl8hydroxy5deazariboflavin AT mouritsenhenrik arobustsynthesisof78didemethyl8hydroxy5deazariboflavin AT christoffersjens arobustsynthesisof78didemethyl8hydroxy5deazariboflavin AT bendermatthias robustsynthesisof78didemethyl8hydroxy5deazariboflavin AT mouritsenhenrik robustsynthesisof78didemethyl8hydroxy5deazariboflavin AT christoffersjens robustsynthesisof78didemethyl8hydroxy5deazariboflavin |